Lipid Profile in Girls with Precocious Puberty: a Systematic Review and Meta-analysis

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2023 Oct 17

PMID 37848909

Authors

Mei Jiang

Ying Gao

Kai Wang

Ling Huang

Affiliations

Soon will be listed here.

Abstract

Objective: Many studies have investigated the impact of precocious puberty on cardiovascular disease (CVD) outcomes and the association between lipid profile levels and precocious puberty. However, the results have been inconsistent. The aim of this meta-analysis was to evaluate whether triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL)and low density lipoprotein (LDL) levels were altered in girls with precocious puberty compared with healthy controls.

Methods: References published before June 2022 in the EMBASE, Cochrane Library, PubMed and Web of Science databases were searched to identify eligible studies. A DerSimonian-Laird random-effects model was used to evaluate the overall standard mean difference (SMD) between precocious puberty and healthy controls. Subgroup analyses and sensitivity analyses were preformed, and publication bias was assessed.

Results: A total of 14 studies featuring 1023 girls with precocious puberty and 806 healthy girls were selected for analysis. The meta-analysis showed that TG (SMD: 0.28; 95% CI: 0.01 to 0.55; P = 0.04), TC (SMD: 0.30; 95% CI: 0.01 to 0.59; P = 0.04), LDL (SMD: 0.45; 95% CI: 0.07 to 0.84; P = 0.02)levels were significantly elevated in girls with precocious puberty. HDL levels did not change significantly (SMD: -0.06; 95% CI: -0.12 to 0.61; P = 0.62). Subgroup analyses revealed that the heterogeneity in the association between lipid profile and precocious puberty in this meta-analysis may arise from disease type, region, sample size, chronological age, body mass index difference and drug usage.

Conclusion: Lipid profile levels altered in girls with precocious puberty compared with healthy controls. In order to minimize the risk of CVD morbidity and mortality, early interventions were needed to prevent obesity in children and adolescents, especially those with precocious puberty.

Citing Articles

Changes in blood glucose and lipid metabolism levels in children with central precocious puberty and its correlation with obesity.

Cui X, Sun X, Li Q, Chen Z Front Pediatr. 2025; 12():1488522.

PMID: 39840310 PMC: 11747382. DOI: 10.3389/fped.2024.1488522.

Exploring the Influence of Age at Menarche on Metabolic Syndrome and Its Components Across Different Women's Birth Cohorts.

Farahmand M, Mousavi M, Azizi F, Ramezani Tehrani F Endocrinol Diabetes Metab. 2024; 7(6):e70015.

PMID: 39548722 PMC: 11568236. DOI: 10.1002/edm2.70015.

Lipid Profile and Triglyceride-Glucose Index (TyG) Alterations in a Single-Center Cohort of Children Diagnosed with Central Precocious Puberty.

Sodero G, Pane L, Malavolta E, Rotunno G, Sessa L, Fraccascia B Children (Basel). 2024; 11(6).

PMID: 38929219 PMC: 11201813. DOI: 10.3390/children11060639.

References

Jacobsen B, Oda K, Knutsen S, Fraser G . Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88. Int J Epidemiol. 2009; 38(1):245-52. PMC: 2722816. DOI: 10.1093/ije/dyn251. View

Ibanez L, Valls C, Marcos M, Ong K, Dunger D, de Zegher F . Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab. 2004; 89(9):4331-7. DOI: 10.1210/jc.2004-0463. View

Hur J, Park S, Jung M, Kang S, Kwon A, Chae H . Insulin resistance and bone age advancement in girls with central precocious puberty. Ann Pediatr Endocrinol Metab. 2017; 22(3):176-182. PMC: 5642083. DOI: 10.6065/apem.2017.22.3.176. View

Ibanez L, DiMartino-Nardi J, Potau N, Saenger P . Premature adrenarche--normal variant or forerunner of adult disease?. Endocr Rev. 2001; 21(6):671-96. DOI: 10.1210/edrv.21.6.0416. View

Chiocca E, Dati E, Baroncelli G, Mora S, Parrini D, Erba P . Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height. Neuroendocrinology. 2009; 89(4):441-7. DOI: 10.1159/000197862. View

Boyne M, Osmond C, Fraser R, Reid M, Taylor-Bryan C, Soares-Wynter S . Developmental origins of cardiovascular risk in Jamaican children: the Vulnerable Windows Cohort study. Br J Nutr. 2010; 104(7):1026-33. DOI: 10.1017/S0007114510001790. View

Teixeira R, Ginzbarg D, Rodrigues Freitas J, Fucks G, Silva C, Bordallo M . Serum leptin levels in premature pubarche and prepubertal girls with and without obesity. J Pediatr Endocrinol Metab. 2004; 17(10):1393-8. DOI: 10.1515/jpem.2004.17.10.1393. View

Velazquez E, Mendoza S, Wang P, Glueck C . Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism. 1997; 46(4):454-7. DOI: 10.1016/s0026-0495(97)90066-4. View

Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M . Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993; 76(6):1599-603. DOI: 10.1210/jcem.76.6.8501168. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Zurita-Cruz J, Medina-Bravo P, Manuel-Apolinar L, Damasio-Santana L, Wakida-Kusunoki G, Padilla-Rojas M . Resistin levels are not associated with obesity in central precocious puberty. Peptides. 2018; 109:9-13. DOI: 10.1016/j.peptides.2018.09.009. View

12.

Ucar A, Saka N, Bas F, Hatipoglu N, Bundak R, Darendeliler F . Reduced atherogenic indices in prepubertal girls with precocious adrenarche born appropriate for gestational age in relation to the conundrum of DHEAS. Endocr Connect. 2013; 2(1):1-10. PMC: 3680958. DOI: 10.1530/EC-12-0059. View

13.

Larque E, Gil-Campos M, Villada I, Ramirez-Tortosa M, Canete R, Gil A . Postprandial plasma adiponectin response is reduced in prepubertal premature pubarche girls. Metabolism. 2010; 59(9):1319-26. DOI: 10.1016/j.metabol.2009.12.009. View

14.

Shi J, Luo D, Weng H, Zeng X, Lin L, Chu H . Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020; 11(5):641-654. DOI: 10.1002/jrsm.1429. View

15.

Garn S, Lavelle M, Rosenberg K, Hawthorne V . Maturational timing as a factor in female fatness and obesity. Am J Clin Nutr. 1986; 43(6):879-83. DOI: 10.1093/ajcn/43.6.879. View

16.

Sorensen K, Mouritsen A, Mogensen S, Aksglaede L, Juul A . Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression. J Clin Endocrinol Metab. 2010; 95(8):3736-44. DOI: 10.1210/jc.2010-0731. View

17.

de Zegher F, Garcia Beltran C, Lopez-Bermejo A, Ibanez L . Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation. Horm Res Paediatr. 2017; 89(2):136-140. DOI: 10.1159/000479369. View

18.

Novello L, Speiser P . Premature Adrenarche. Pediatr Ann. 2018; 47(1):e7-e11. DOI: 10.3928/19382359-20171214-04. View

19.

Berberoglu M . Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol. 2011; 1(4):164-74. PMC: 3005651. DOI: 10.4274/jcrpe.v1i4.3. View

20.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View